Latest Breaking News On - Prognostic value - Page 1 : comparemela.com

Adding cardiovascular biomarkers to established risk factors increases risk prediction

Adding cardiovascular biomarkers to established risk factors increases risk prediction
medicalxpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medicalxpress.com Daily Mail and Mail on Sunday newspapers.

Nordrhein westfalenUnited statesJohannes tobias neumannThomasa gazianoUniversity medical center hamburgJournal of the american medical associationAmerican medicalTobias neumannUniversity medical center hamburg eppendorfPrognostic valueCardiovascular biomarkersCan cardiovascular risk assessment be improved

Advanced CT test simulates blood flow to evaluate risk in patients with angina

Denmark: A normal coronary CT angiography (CTA)-derived fractional flow reserve (FFR) test result identified patients with a low 3-year risk of all-cause death or nonfatal spontaneous MI, both in the.

Allan roholdHans mickleyJesperm jensenHans erikCampbell rogersManeshr patelKristiant madsenKoen niemanErik parnerTimothya fairbairnSarah mullenUniversity hospital of southern denmarkDepartment of cardiologyUniversity hospitalSouthern denmarkAssessing diagnostic value

Study: B-type natriuretic peptides lose prognostic value for clinical outcomes in LVAD recipients with cardiogenic shock

Study: B-type natriuretic peptides lose prognostic value for clinical outcomes in LVAD recipients with cardiogenic shock
medicalxpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medicalxpress.com Daily Mail and Mail on Sunday newspapers.

United statesPankaj aroraDivision of cardiovascular diseaseBirmingham marnixAmerican journalClinical correlatesPrognostic valueB type natriuretic peptide

Positive results from the Phase II study of uTRACE in brain cancer presented at the World Molecular Imaging Congress (WMIC) 2023 in Prague

Curasight A/S ("Curasight" or the "Company" - TICKER: CURAS) announces today that the previously announced results from the investigator-initiated phase II study using uPAR-PET (uTRACE®) in primary brain cancer have been presented in an oral presentation at the World Molecular Imaging Congress (WMIC) 2023 in .

Czech republicUlrich krasilnikoffCurasightas curasightAleena azamUniversity of copenhagenWorld molecular imaging congressPrimary gliomasPrognostic valueTargeted radionuclideMolecular imagingSpringer publisher

Positive results from the Phase II study of uTRACE in brain cancer presented at the World Molecular Imaging Congress (WMIC) 2023 in Prague

/PRNewswire/ Curasight A/S ("Curasight" or the "Company" - TICKER: CURAS) announces today that the previously announced results from the.

Czech republicAleena azamUlrich krasilnikoffWorld molecular imaging congressUniversity of copenhagenPrimary gliomasPrognostic valueTargeted radionuclideMolecular imagingSpringer publisherPositron emissions tomographyRadionuclide therapy